Redefining the role of patient support programs at PMRC US 2016
Historically, pharmaceutical manufacturers implemented support programs largely as a way to address patient non-adherence; these programs were often single-based solutions with the intent of fitting with the mass market’s needs. With the changing landscape, however, the focus is now starting to move away from simply an adherence program and towards a holistic disease management program.
At the 2016 US Pharma Market Research Conference (PMRC), we shared how to reinvent patient support programs by identifying which services are most valued by patients and focusing resources on patient-centric enhancements and personalization.
Redefining the role of patient support programs:
Shifting the focus towards patient-centric offerings
Alex Zhu, Manager
Ariel Herrlich, Analyst
The recent shift toward consumerism and patient empowerment is driving companies to reevaluate the role and design of patient support programs. Historically, pharmaceutical manufacturers implemented support programs largely as a way to address patient non-adherence.
These programs were often single-based solutions designed to meet mass market needs. Next generation patient support programs will go beyond simple adherence to address holistic disease management through individualized, patient-centric service offerings.
Using a case study, we illustrated:
- How to evaluate your current patient support program offerings, using a combination of standard and non-standard metrics and exercises
- Re-define what “value” means in a world of patient-centricity and personalized care
- Assess the impact/ROI of potential new service offerings and enhancements
Want to know more? Don’t hesitate to give us a call or drop an email!